UPDATE 2-Teva settles patent suit with Pfizer over Celebrex
April 17, 2014 at 12:56 PM EDT
April 17 (Reuters) - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December.